Clario vs Medidata eCOA(eCOA)

Sponsors, CROs and academic research teams choosing an eCOA platform for a regulated clinical trial.

Scope Electronic clinical outcome assessment (eCOA) platforms that capture patient-reported (ePRO), clinician-reported, observer-reported and performance outcomes in regulated clinical trials, as a sponsor, CRO or academic research team would shortlist them.

Guide updated How we compare

Compare within eCOA

Study fit, side by side

These notes describe the products in the eCOA guide.

Clario

Best for
Global pivotal trials that combine eCOA with cardiac, respiratory, imaging or sensor endpoints
What to consider
Clario has the deepest enterprise eCOA profile here: studies in 120+ countries and 100+ languages, a named eCOA science team and pre-validated assessment libraries. It says it has supported 70% of FDA and EMA new drug approvals since 2015 across its endpoints. Builds are delivered by Clario and prices are not published.
Read product profile

Medidata eCOA

Best for
Large sponsors and CROs that already run Rave EDC and want eCOA in the same platform
What to consider
Medidata eCOA lists 2,500+ COAs, 200+ languages and dialects and 1,600+ studies, and data flows straight into Rave EDC. Study builders can configure it in Medidata Designer, with an average study start of 8 weeks. Prices are not published.
Read product profile

Compare the features

Both products use the same category definitions. Product order is editorial; products are not ranked.

Full eCOA feature comparison

Single and double checks describe documented support for an individual feature. Double checks use the extended definition for that feature. Unknown means the available evidence does not establish support.

Expand a feature definition or support note for context and its original source.

Clario vs Medidata eCOA (eCOA): category feature evidence and sources. Products are not ranked.
Category featureClarioMedidata eCOA
Validated instrument library and licensing
Feature definitions
Supported
A library of outcome-assessment instruments is documented.
Extended support
A validated or instrument-author-approved library plus managed instrument licensing are documented.
Supported

Pre-built, validated assessment libraries, the Rapid Start assessment catalog and an eCOA Science Services team with named scientists.

Source
About this support label

Validated libraries and science services are documented; managed licensing is not established.

Extended support

2,500+ COAs and a global instrument library for reusing builds and translations; Medidata also offers a validated instrument license management service.

Source
About this support label

A reusable instrument library is paired with a validated instrument license-management service.

Regulatory compliance and track record
Feature definitions
Supported
Relevant trial or security controls are stated.
Extended support
Relevant trial controls plus a public ISO/SOC certificate or audit report are documented; a certification claim or logo alone is insufficient.
Supported

States it has supported 70% of FDA and EMA new drug approvals since 2015 (company-wide, all endpoint types); ISO 27001:2022 and SOC 2 Type II are published separately.

Source
About this support label

ISO/SOC certifications are stated; this note does not establish a public certificate or audit report.

Supported

Medidata says its AI functionality supports 80% of 2025 FDA novel drug approvals (company-wide platform claim, not eCOA alone); position statements on Part 11, Annex 11 and ICH E6 are published.

Source
About this support label

Part 11, Annex 11 and ICH E6 statements are documented; the approval claim is company-wide.

Global scale and languages
Feature definitions
Supported
Multicountry use or multilingual/localized participant support is documented.
Extended support
Both multicountry use and multilingual/localized participant support are documented.
Extended support

Studies in over 120 countries and over 100 languages; 25 years of DCT and hybrid trials.

Source
About this support label

The note reports studies across countries and languages.

Supported

200+ languages and dialects, 1,600+ eCOA studies, 90K+ sites and 460+ sponsors.

Source
About this support label

Languages and study volumes are documented; this note does not establish multicountry use.

Capture modes and integrations
Feature definitions
Supported
Electronic outcome capture and a connection to another trial system or device are documented.
Extended support
Capture on participant-owned and provisioned devices plus wearable or sensor integration are documented.
Extended support

BYOD, web or provisioned devices, plus pre-validated connected devices (CGM, glucose meters, Opal motion sensors) integrated with the eCOA device.

Source
About this support label

BYOD and provisioned devices are offered with integrated, pre-validated connected devices.

Supported

BYOD (iOS, Android), provisioned devices and web; data flows into Rave EDC; Sensor Cloud is listed among Patient Cloud applications.

Source
About this support label

BYOD, provisioned devices and Rave data flow are documented; listing Sensor Cloud does not establish sensor integration.

Time to launch and self-service build
Feature definitions
Supported
A study build process, self-service builder or launch timeframe is documented.
Extended support
Study teams can configure the study themselves, with a stated build or launch timeframe.
Supported

eCOA Swift deploys early-phase oncology trials in as little as 2 weeks and Rapid Start offers pre-configured assessments; builds are vendor-delivered, no self-service designer published.

Source
About this support label

Vendor-delivered oncology deployment timing is stated; a self-service designer is not documented.

Extended support

Medidata Designer lets study builders configure questionnaires with drag-and-drop templates; average study start 8 weeks versus a 12-week industry standard.

Source
About this support label

Study builders configure questionnaires in Designer, with an average eight-week study start.

Published pricing and terms
Feature definitions
Supported
A production pricing basis, model or contract terms beyond a sales contact are published.
Extended support
Numerical production prices or a free production option with its conditions are published.
Unknown

Not published: no price, pricing model or contract terms on the vendor site; pricing by sales contact only.

Source
About this support label

Sales contact alone does not establish a published pricing model, prices or contract terms.

Unknown does not mean unavailable. The public evidence does not establish support under this category’s definition.

Supported

No prices published; Medidata's public Patient Cloud service descriptions set out contract terms, such as devices provisioned on a rental basis, caps on fee adjustments and early-termination fees.

Source

The guide update date reflects guide edits. Vendor statements are attributed in the evidence.

Keep the category in view

Compare these products with the other tools in the eCOA guide using the same feature definitions.

More eCOA comparisons featuring one of these products.